Furthermore, it has been shown that tumor-cell apoptosis induced by gemcitabine can enhance DC cross-presentation of tumor antigen to CD8+ T cells [18], but it is not yet clear whether CRT translocation, mobilization of HMGB1, and ATP are involved in the process. Here, HMGB1 is linked to neoplasm.